PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Peritonitis D010538 38 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Hematoma D006406 5 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Kerr JS et al. Effects of recombinant interleukin-1 beta on phospholipase A2 activity, phospholipase A2 mRNA levels, and eicosanoid formation in rabbit chondrocytes. 1989 Biochem. Biophys. Res. Commun. pmid:2558648
Leynadier F [Mast cells and basophils in asthma]. 1989 Ann. Biol. Clin. (Paris) pmid:2675683
Hamid-Bloomfield S and Whittle BJ Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C. 1989 Br. J. Pharmacol. pmid:2647205
Kuiper J et al. The role of prostaglandins in endotoxin stimulated glycogenolysis in the liver. 1989 Agents Actions pmid:2653002
Amano N et al. The effect of pentobarbital and ether anesthesia on rat brain PGD2 content. 1989 Agressologie pmid:2610292
Shram SI et al. [Preparation and properties of prostaglandin D2 labelled with tritium with high molar radioactivity]. 1989 Bioorg. Khim. pmid:2590255
Yamada K [The effect of prostaglandin D2 on rat testicular testosterone levels]. 1989 Nihon Naibunpi Gakkai Zasshi pmid:2591605
Goto H et al. The role of prostaglandin D2 in the genesis of indomethacin-induced gastric lesions in rats. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595317
Busshardt E et al. Regulation of hepatic parenchymal and non-parenchymal cell function by the diadenine nucleotides Ap3A and Ap4A. 1989 Biochim. Biophys. Acta pmid:2563228
Trist DG et al. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase. 1989 Br. J. Pharmacol. pmid:2466517
Triggiani M et al. Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468619
Charlesworth EN et al. Cells and secretagogues involved in the human late-phase response. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468620
Church MK et al. Interaction of neuropeptides with human mast cells. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468622
Charlesworth EN et al. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. 1989 J. Clin. Invest. pmid:2468688
Charlesworth EN et al. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. 1989 J. Allergy Clin. Immunol. pmid:2469708
Church MK et al. Mast cells, neuropeptides and inflammation. 1989 Agents Actions pmid:2473641
Robinson C et al. The metabolism of prostaglandin D2. Evidence for the sequential conversion by NADPH and NAD+ dependent pathways. 1989 Biochem. Pharmacol. pmid:2818626
van Overveld FJ Mediator release from human lung mast cell subtypes in chronic bronchitis and emphysema. 1989 Agents Actions pmid:2473645
Lapointe DS and Olson MS Platelet-activating factor-stimulated hepatic glycogenolysis is not mediated through cyclooxygenase-derived metabolites of arachidonic acid. 1989 J. Biol. Chem. pmid:2501299
Robinson C et al. The IgE- and calcium-dependent release of eicosanoids and histamine from human purified cutaneous mast cells. 1989 J. Invest. Dermatol. pmid:2504819
Reshef A et al. The pattern and kinetics in human skin of erythema and mediators during the acute and late-phase response (LPR). 1989 J. Allergy Clin. Immunol. pmid:2478604
Marone G et al. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion. 1989 Life Sci. pmid:2480501
Giles H et al. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. 1989 Br. J. Pharmacol. pmid:2924081
Reiss TF et al. Local mediator release after antigen challenge of a bronchial segment in allergic dogs. 1989 Am. J. Physiol. pmid:2481982
Levi-Schaffer F and Shalit M Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells activated with peptides. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2482257
Beasley RC et al. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. 1989 J. Appl. Physiol. pmid:2525122
Watanabe K [Structure and function of prostaglandin F synthetase]. 1989 Seikagaku pmid:2693551
Preclik G et al. Alimentary tract and pancreas. Stimulation of mucosal prostaglandin synthesis in human stomach and duodenum by antacid treatment. 1989 Gut pmid:2703138
Napier FE and Temple DM The influence of xanthines on the contractile responses of PGF2 alpha and PGD2 in human parenchymal strips. 1989 Prostaglandins pmid:2772222
Dieter P et al. 4-Bromophenacyl bromide inhibits prostaglandin D2 synthesis from arachidonic acid rather than phospholipase A2 activity in liver macrophages. 1989 Biol. Chem. Hoppe-Seyler pmid:2775481
Coe JY et al. A fetal-instrumented model to study age-specific responses to leukotriene D4 and prostaglandin D2 in unsedated newborn lambs. 1989 Can. J. Physiol. Pharmacol. pmid:2776077
Ehara H [An experimental study on antitumor effect of prostaglandin D2]. 1989 Nihon Geka Gakkai Zasshi pmid:2796985
Thierauch KH et al. ZK 110 841--a selective and potent prostaglandin D2 analogue. 1989 Prog. Clin. Biol. Res. pmid:2798462
Ashida Y et al. A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids. 1989 Prostaglandins pmid:2748922
Raisz LG and Woodiel FN Effect of alterations in the cyclopentane ring on bone resorptive activity of prostaglandin. 1989 Prostaglandins pmid:2727307
Rodriguez y Baena R et al. Effects of nicardipine on the ex vivo release of eicosanoids after experimental subarachnoid hemorrhage. 1989 J. Neurosurg. pmid:2585083
Marone G Control mechanisms of mediator release in human basophils and mast cells. 1988 Nov-Dec Immunol. Invest. pmid:2465995
Ikai K and Imamura S Prostaglandin D2 in the skin. 1988 Int. J. Dermatol. pmid:3286543
Hardy CC et al. Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. 1988 J. Appl. Physiol. pmid:3288608
Pienkowski MM et al. Prostaglandin D2 and histamine during the immediate and the late-phase components of allergic cutaneous responses. 1988 J. Allergy Clin. Immunol. pmid:3292634
Ito S et al. Problems in production of prostaglandin D2-specific antibody. 1988 Eicosanoids pmid:3273218
Saito K et al. Blood components contribute to rise in gerbil brain levels of leukotriene-like immunoreactivity after ischemia and reperfusion. 1988 Stroke pmid:3274043
Giles H and Leff P The biology and pharmacology of PGD2. 1988 Prostaglandins pmid:3283848
Featherstone RL et al. Active sensitization of guinea-pig airways in vivo enhances in vivo and in vitro responsiveness. 1988 Eur. Respir. J. pmid:3229483
Koh T et al. Serotonin involvement in the inhibition of luteinizing hormone (LH) release induced by prostaglandin D2 (PGD2) in castrated male rats. 1988 Eur. J. Pharmacol. pmid:2969338
Broide DH et al. Functional and biochemical characterization of rat bone marrow derived mast cells. 1988 J. Immunol. pmid:2974057
Schulman ES et al. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. 1988 J. Clin. Invest. pmid:2449462
Robinson C et al. The immunoglobulin E- and calcium-dependent release of histamine and eicosanoids from human dispersed mastocytosis spleen cells. 1988 J. Invest. Dermatol. pmid:2450144
Undem BJ and Adams GK An analysis of the functional interactions of selected contractile agonists in the guinea pig isolated trachea. 1988 J. Pharmacol. Exp. Ther. pmid:2839671
Holgate ST et al. The contribution of mast cell mediators to acute allergic reactions in human skin and airways. 1988 Allergy pmid:2451448